VolitionRx (NYSE-A:VNRX) told investors it has secured €5 million (roughly $5.5 million) in financing from Belgium’s Wallonie Entreprendre (WE) for the.
VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, welcomed Ambassador Michael M. Adler, U.S. Ambassador to the Kingdom of Belgium for a tour of its purpose-built research, development and manufacturing facilities situated in Isnes, Belgium.
VolitionRx (NYSE-A:VNRX), the multinational epigenetics company, said it was “delighted” to host Ambassador Michael Adler, the US Ambassador to the Kingdom.
VolitionRx Limited (NYSE:NYSE:VNRX) Q2 2022 Earnings Conference Call August 11, 2022 08:30 AM ET Company Participants Scott Powell - IR Cameron Reynolds - CEO Dr.